Previous non-clinical studies and investigations performed in healthy volunteers has established that GPR119 are able to increase the level of circulating incretins including GLP-1, GIP, and tyrosine-tyrosine peptide (PYY), reducing the hyperglycemia after oral glucose load (39). Here, PYY is linked to Hyperglycemia.